Selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle.
about
Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscleMetabolic actions of Rho-kinase in periphery and brainRhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migrationA signal transduction pathway model prototype II: Application to Ca2+-calmodulin signaling and myosin light chain phosphorylationEffect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cellsS-nitrosylation in the regulation of gene transcriptionAging, atherosclerosis, and IGF-1Comparative Proteomics Analysis Reveals L-Arginine Activates Ethanol Degradation Pathways in HepG2 Cells.Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylationcGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions.Stimulation of glycogen synthesis by heat shock in L6 skeletal-muscle cells: regulatory role of site-specific phosphorylation of glycogen-associated protein phosphatase 1.Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance.
P2860
Q24657236-7D76001B-B752-4441-8367-A3A99C4498D8Q26864028-F6B5E89E-7768-496D-B693-8C904F94F013Q34178064-2E68276B-892C-4D3E-A8B5-6EF318D465CDQ34186961-8FE0C03C-082E-4A1A-91BE-12106B0579B7Q35005827-13D733AA-B65F-4C09-8DF9-27198059924BQ35131182-9A4D5A9D-05B8-4743-BBB1-06CB3885756FQ35492444-6A519216-62B1-4E93-A670-249E107E22CDQ35947440-AE0D3A3E-EEF9-49E5-8498-D5420B912AB0Q35959936-89B222C7-4D06-4637-AE62-A189BAA8759AQ36857263-25843109-238B-431F-8D23-A782C0307B3BQ37100009-0649A173-AE17-4451-8B66-024B85F296B9Q38364180-93BC4801-18B8-4B2B-AA4A-F71216F68C1CQ38521263-B7E816B1-7E13-483B-B618-9074158C5518Q42447186-6DA90409-348B-49F1-99EC-B938A9647539Q43295222-63BA88C1-AB15-471F-9713-87D780744EF3Q45032185-0887775A-FBBF-4201-9F54-584AB3E8C34C
P2860
Selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Selected contribution: insulin ...... ion in vascular smooth muscle.
@en
Selected contribution: insulin ...... ion in vascular smooth muscle.
@nl
type
label
Selected contribution: insulin ...... ion in vascular smooth muscle.
@en
Selected contribution: insulin ...... ion in vascular smooth muscle.
@nl
prefLabel
Selected contribution: insulin ...... ion in vascular smooth muscle.
@en
Selected contribution: insulin ...... ion in vascular smooth muscle.
@nl
P2093
P2860
P1476
Selected contribution: insulin ...... ion in vascular smooth muscle.
@en
P2093
P2860
P304
P356
10.1152/JAPPL.2001.91.3.1475
P407
P577
2001-09-01T00:00:00Z